| Literature DB >> 35783766 |
Xinxin Zhao1, Siqi Tong2, Ye Yang3.
Abstract
Purpose: This study aimed to assess the evidence of the association between positive psychological resources and quality of life in patients with cancer.Entities:
Keywords: cancer; meta-analysis; positive psychological resources; quality of life; self-efficacy
Year: 2022 PMID: 35783766 PMCID: PMC9245894 DOI: 10.3389/fpsyg.2022.883157
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
FIGURE 1Study flow diagram.
Characteristics of included studies.
| Study | Location | Sample size | Mean age (year) | Cancer type | Positive psychological resources (PPR) | Instruments for assessing PPR | Instruments for assessing QoL | Study quality |
|
| Sweden | 39 | 71.7 | Colorectal | Self-efficacy | MFS | EORTC QLQ-C30 | 19 |
|
| Germany | 40 | 49.2 | Breast | Self-esteem | RSES | FACT-B | 19 |
|
| Taiwan | 40 | 16.4 | Mixed | Resilience | RS | MMOL-AF | 18 |
|
| United States | 51 | 58.47 | Breast | Optimism | LOT | FLIC | 18 |
|
| United States | 73 | 60.12 | Breast | Self-efficacy | PAAI | MQOL | 19 |
|
| Israel | 73 | 50.85 | Mixed | Self-efficacy | NGSE | FACT-GP | 18 |
|
| China | 76 | 54.6 | Cervical | Self-efficacy | SUPPH | FACT-G | 18 |
|
| Greece | 90 | 61.17 | Breast | Self-efficacy | GSE | LASA | 18 |
|
| Germany | 95 | 55.7 | Breast | Optimism | LOT | EORTC QLQ-C30 | 19 |
|
| China | 98 | 47.02 | Breast | Resilience | CD-RISC | FACT-B | 19 |
|
| United Kingdom | 98 | 64 | Head and neck | Resilience | CD-RISC | UW-QoL | 18 |
|
| United States | 99 | 63 | Bladder | self-efficacy | GSE | FACT-BI | 19 |
|
| China | 100 | 45.65 | Cervical, endometrial, ovarian | Resilience | CD-RISC | FACT-G | 18 |
|
| United States | 112 | 58.89 | Breast | Self-efficacy | CBI | FACT-G | 17 |
|
| South Korea | 115 | 11–18 | Mixed | Self-efficacy | SES | PedsQL 4.0 | 18 |
|
| China | 118 | 67.45 | Mixed | Resilience | RS-14 | FACT-G | 18 |
|
| China | 119 | 45.4 | Breast | Resilience | CD-RISC | FACT-G | 19 |
|
| China | 120 | 20–50 | Breast | Resilience | CD-RISC | FACT-G | 18 |
|
| China | 121 | 47.01 | Breast | Hope, Self-efficacy | HHI, GSES | FACT-B | 17 |
|
| China | 124 | 49.54 | Breast | Resilience | CD-RISC | FACT-B | 19 |
|
| Australia | 126 | 62.1 | Ovarian | Hope | HHI | FACT-G | 18 |
|
| China | 128 | 46.89 | Breast | Resilience | CD-RISC | FACT-B | 18 |
|
| China | 128 | 64.7 | Gastric | Self-efficacy | GSES | SQLI | 19 |
|
| South Korea | 129 | 52.09 | Breast | Resilience | RS | FACT-B | 18 |
|
| China | 129 | 56.4 | Colorectal | Resilience | CD-RISC | FACT-G | 18 |
|
| Singapore | 129 | 17.3 | Mixed | Self-esteem | RSES | QoL-CSS | 17 |
|
| Spain | 134 | 54.4 | Breast | Self-esteem | RSES | QLACS | 19 |
|
| China | 134 | 52.6 | Breast | Resilience | CD-RISC | FACT-B | 18 |
|
| South Korea | 136 | 58.8 | Gastric | Self-esteem | SES | QOL-CS | 18 |
|
| Hong Kong | 138 | 10.6 | Leukemia or Brain tumor or Lymphoma | Resilience, | RS-10, RSES | PedsOL 3.0 | 18 |
|
| South Korea | 140 | 48.9 | Breast | Self-efficacy | SESSM-B | FACT-B | 17 |
|
| China | 146 | 6.2 | Mixed | Resilience | CD-RISC | SF-6D | 19 |
|
| China | 147 | 57.51 | Lung | Self-efficacy | SUPPH | FACT-L | 18 |
|
| Taiwan | 150 | 44.8 | Breast | Self-esteem | RSES | OLI-cancer | 17 |
|
| China | 160 | 18 + | Colorectal | Resilience | CD-RISC | EORTC QLQ-C30 | 18 |
|
| Frances | 163 | 58.24 | Mixed | Optimism | LOT | FACT-G | 17 |
|
| China | 172 | 57.3 | Lung | Resilience | CD-RISC | FACT-L | 18 |
|
| Hong Kong | 176 | 12.56 | Mixed | Hope, self-esteem | HHI, RSES | PedsOL 4.0 | 19 |
|
| China | 193 | 67.38 | Liver cancer | Hope | HHI | FACT-Hep | 17 |
|
| China | 193 | 55.46 | Mixed | Hope | HHI | FACT-G | 18 |
|
| Iran | 200 | 51.31 | Mixed | Hope | AHS | EORTC QLQ-C30 | 18 |
|
| Taiwan | 201 | 53.6 | Breast | Self-efficacy | SMSES-B | EORTC QLQ-C30 | 19 |
|
| United Kingdom | 204 | 65.24 | Prostate | Resilience | CD-RISC | PORPUS-P | 18 |
|
| South Korea | 204 | 54.2 | Mixed | Self-efficacy | CSSES | SF-36 | 18 |
|
| China | 206 | 54.6 | Mixed | Self-efficacy | GSES | QOL-CS | 17 |
|
| Portugal | 211 | 13.29 | Mixed | Hope | CHS | DCGM-12 | 19 |
|
| China | 217 | 56.24 | Breast | Self-efficacy | SUPPH | FACT-B | 18 |
|
| China | 224 | 47.54 | Breast | Hope | HHI | FACT-B | 17 |
|
| China | 230 | 56.13 | Oral | Hope | HHI | FACT-H&N | 19 |
|
| China | 231 | 48.15 | Breast | Resilience | CD-RISC | FACT-B | 18 |
|
| China | 237 | 18 + | Cervical | Self-efficacy | SUPPH | FACT-Cx | 18 |
|
| China | 238 | 55.7 | Mixed | Self-efficacy | CBI | QOL-CS | 17 |
|
| China | 265 | 50.24 | Cervical | Hope | HHI | WHOQOL-BREF | 18 |
|
| China | 273 | 46.91 | Breast | Resilience | CD-RISC | QOL-CS | 17 |
|
| China | 284 | 49 | Lung, breast and liver | Resilience | CD-RISC | EORTC QLQ-C30 | 18 |
|
| United Kingdom | 286 | 67 | Prostate | Self-esteem | MSES | FACT-G | 19 |
|
| Jordan | 320 | 51.9 | Colorectal | Hope | HHI | FACT-C | 19 |
|
| Hong Kong | 334 | 64.66 | Lung | Optimism | LOT | FACT-G | 18 |
|
| United States | 341 | 57.9 | Mixed | Self-efficacy | CBI | MQOL-C | 18 |
|
| Germany | 354 | 61.2 | Breast and gynecological | Optimism, | LOT, GSES | EORTC QLQ-C30 | 17 |
|
| China | 365 | 63.76 | Bladder | Resilience, hope | RS-14, AHS | FACT-BL | 19 |
|
| China | 404 | 67.06 | Prostate | self-efficacy | GSES | FACT-P | 18 |
|
| Australia | 429 | 67 | Metastatic colorectal | Hope | SHS, LOT | EQ-5D | 18 |
|
| China | 450 | 47.76 | Breast | Hope | HHI | FACT-B | 17 |
|
| China | 452 | 62.1 | Lung | Self-efficacy | GSES | SF-36 | 19 |
|
| Malaysia | 953 | 46.45 | Mixed | Self-esteem | RSES | WHOQOL-BREF | 17 |
AHS, Adult Hope Scale; CBI, Cancer Behavior Inventory; CD-RISC, Connor-Davidson resilience scale; CHS, Children’s Hope Scale; CSSES, Cancer Survivors’ Self-Efficacy Scale; GSE, General Self-efficacy beliefs Scale; HHI, Herth Hope Index; LOT, Life Orientation Test; MFS, Maintain Function Scale; MSES, Masculine Self-Esteem Scale; NGSE, New General Self-Efficacy Scale; PAAI, Physical Activity Assessment Inventory; RSES, Rosenberg Self-Esteem Scale; SES, Self-Efficacy-Scale; SESSM-B, Self-Efficacy Scale for Self-Management of Breast Cancer; SHS, State Hope Scale; SMSES-B, Symptom-Management Self-Efficacy Scale-Breast Cancer; SQLI, Spitzer Quality of Life Index; SUPPH, Strategies Used by People to Promote Health.
GCGM, DISABKIDS Chronic Generic Measure; EORTC QLQ, European Organization for Research and Treatment of Cancer quality of life, Questionnaire; EQ-5D, European Quality of Life-5 Dimensions; FACT-B, Functional Assessment of Cancer Therapy Breast cancer; FACT-BL, Functional Assessment of Cancer Therapy-Bladder; FACT-C, Functional Assessment of Cancer Therapy-Colorectal cancer; FACT-G, Functional Assessment of Cancer Therapy-General; FACT-H&N, Functional Assessment of Cancer Therapy-Head and Neck; FACT-Hep, Functional Assessment of Cancer Therapy-Hepatobiliary; FACT-L, Functional Assessment of Cancer Therapy-Lung; FLIC, Functional Living Index-Cancer; LASA, Linear Analog Scale Assessment; MMQL-AF, Minneapolis-Manchester Quality of Life Instrument-Adolescent Form; MQOL, McGill Quality of Life Questionnaire; MQOL-C, Multidimensional Quality of Life Scale-Cancer; PedsQL, Pediatric Quality-of-Life; QLACS, Quality of Life in Adult Cancer Survivors; QLI, Quality-of-Life Index; QOL-CS, Quality of Life-Cancer Survivors; SF, Short Form; UW-QoL, University of Washington quality of life; WHOQOL-BREF, World Health Organization’ s Quality of Life Questionnaire-Brief.
FIGURE 2Effect sizes of the correlation between five positive psychological resources and quality of life.
Correlations between positive psychological resources and quality of life in cancer patients: subgroup analysis.
| Subgroup |
| |||
|
| ||||
| Participants | 0.251 | |||
| Minors | 3 | 0.58 (0.40, 0.76) | 58.0 | |
| Adults | 18 | 0.73 (0.54, 0.91) | 95.5 | |
|
| ||||
| Participants | 0.934 | |||
| Minors | 2 | 0.48 (0.14, 0.83) | 91.5 | |
| Adults | 12 | 0.50 (0.43, 0.56) | 70.9 | |
| Specific instruments for quality of life | 0.123 | |||
| No | 2 | 0.43 (0.35, 0.50) | 0.0 | |
| Yes | 12 | 0.51 (0.43, 0.58) | 75.2 | |
|
| ||||
| Specific instruments for self-efficacy | 0.228 | |||
| No | 13 | 0.49 (0.39, 0.59) | 85.5 | |
| Yes | 10 | 0.58 (0.47, 0.70) | 84.1 | |
| Specific instruments for quality of life | 0.053 | |||
| No | 4 | 0.52 (0.43, 0.60) | 53.4 | |
| Yes | 19 | 0.65 (0.54, 0.76) | 84.9 | |
|
| ||||
| Participants | 0.659 | |||
| Minors | 3 | 0.40 (0.12, 0.69) | 89.1 | |
| Adults | 5 | 0.49 (0.24, 0.73) | 96.6 |
FIGURE 3Publication bias based on the funnel plots.